Page last updated: 2024-09-04

kolaviron and dimethylnitrosamine

kolaviron has been researched along with dimethylnitrosamine in 1 studies

Compound Research Comparison

Studies (kolaviron)	Trials (kolaviron)	Recent Studies (post-2010) (kolaviron)	Studies (dimethylnitrosamine)	Trials (dimethylnitrosamine)	Recent Studies (post-2010) (dimethylnitrosamine)
103	0	73	2,874	6	498

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Farombi, EO; Shrotriya, S; Surh, YJ	1

Other Studies

1 other study(ies) available for kolaviron and dimethylnitrosamine

Article	Year
Kolaviron inhibits dimethyl nitrosamine-induced liver injury by suppressing COX-2 and iNOS expression via NF-kappaB and AP-1. Life sciences, 2009, Jan-30, Volume: 84, Issue:5-6 Topics: Animals; Antioxidants; Blotting, Western; Chemical and Drug Induced Liver Injury; Cyclooxygenase 2; Dimethylnitrosamine; Electrophoretic Mobility Shift Assay; Flavonoids; Glutathione; Lipid Peroxidation; Male; NF-kappa B; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Transcription Factor AP-1	2009

Article

Year

Kolaviron inhibits dimethyl nitrosamine-induced liver injury by suppressing COX-2 and iNOS expression via NF-kappaB and AP-1.

Life sciences, 2009, Jan-30, Volume: 84, Issue:5-6

Topics: Animals; Antioxidants; Blotting, Western; Chemical and Drug Induced Liver Injury; Cyclooxygenase 2; Dimethylnitrosamine; Electrophoretic Mobility Shift Assay; Flavonoids; Glutathione; Lipid Peroxidation; Male; NF-kappa B; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Transcription Factor AP-1

2009